Jazz Pharmaceuticals PLC (JAZZ) — Cash Flow-to-Debt Ratio
Jazz Pharmaceuticals PLC (JAZZ) has a Cash Flow-to-Debt Ratio of 0.06x as of March 2026, meaning its operating cash flow of $408.20 Million could theoretically repay 0% of its total liabilities ($7.33 Billion) in one year. See Jazz Pharmaceuticals PLC (JAZZ) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jazz Pharmaceuticals PLC Cash Flow-to-Debt Ratio (2005–2025)
Historical debt coverage capacity for Jazz Pharmaceuticals PLC across 21 annual periods. Also explore Jazz Pharmaceuticals PLC (JAZZ) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Jazz Pharmaceuticals PLC (2005–2025)
Year-by-year debt coverage analysis for Jazz Pharmaceuticals PLC. For market capitalisation and broader financial context, see how much is Jazz Pharmaceuticals PLC worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.18x | $1.36 Billion | $7.34 Billion | ▲ +4.8% |
| 2024 | 0.18x | $1.40 Billion | $7.92 Billion | ▲ +23.6% |
| 2023 | 0.14x | $1.09 Billion | $7.66 Billion | ▼ -13.1% |
| 2022 | 0.16x | $1.27 Billion | $7.75 Billion | ▲ +75.7% |
| 2021 | 0.09x | $778.51 Million | $8.33 Billion | ▼ -70.1% |
| 2020 | 0.31x | $899.65 Million | $2.88 Billion | ▼ -2.2% |
| 2019 | 0.32x | $776.40 Million | $2.43 Billion | ▼ -2.1% |
| 2018 | 0.33x | $798.90 Million | $2.45 Billion | ▲ +13.6% |
| 2017 | 0.29x | $693.09 Million | $2.41 Billion | ▲ +42.3% |
| 2016 | 0.20x | $590.54 Million | $2.92 Billion | ▼ -33.1% |
| 2015 | 0.30x | $531.94 Million | $1.76 Billion | ▲ +46.5% |
| 2014 | 0.21x | $405.76 Million | $1.97 Billion | ▼ -31.5% |
| 2013 | 0.30x | $283.62 Million | $942.69 Million | ▲ +1.8% |
| 2012 | 0.30x | $249.75 Million | $845.20 Million | ▼ -88.2% |
| 2011 | 2.49x | $151.60 Million | $60.78 Million | ▲ +345.6% |
| 2010 | 0.56x | $58.87 Million | $105.18 Million | ▲ +735.3% |
| 2009 | -0.09x | $-15.88 Million | $180.23 Million | ▲ +85.8% |
| 2008 | -0.62x | $-130.23 Million | $210.38 Million | ▼ -16.5% |
| 2007 | -0.53x | $-81.09 Million | $152.56 Million | ▼ -262.3% |
| 2006 | -0.15x | $-57.35 Million | $390.87 Million | ▲ +20.4% |
| 2005 | -0.18x | $-52.16 Million | $283.03 Million | — |